141
Views
36
CrossRef citations to date
0
Altmetric
Review

The management of Paget's disease of the vulva*

, , &
Pages 124-128 | Published online: 02 Jul 2009

References

  • Baehrendtz H., Einhorn N., Pettersson F. and Silfversward C. (1994) Paget's disease of the vulva: the Radiumhemmet series 1975-1990. International Journal of Gynecological Cancer, 4, 1 — 6.
  • Barlow R. J., Ramnarain N., Smith N., Mayou B., Markey A. C. and Walker N. P. (1996) Excision of selected skin tumours using Mohs' micrographic surgery with horizontal paraffin-em-bedded sections. British Journal of Dermatology,135,911 —917.
  • Becker-Wegerich P. M., Fritsch C., Schulte K. W., Megahed M., Neuse W., Goerz G., Stahl W. and Ruzicka T. (1998) Carbon dioxide laser treatment of extramammary Paget's disease guided by photodynamic diagnosis. British Journal of Dermatology, 138, 169–172.
  • Brown R. S. D., Lankester K. J., McCormack M., Power D. A. and Spittle M. F. (2002) Radiotherapy for perianal Paget's disease. Clinical Oncology, 14, 272 — 284.
  • Chanda J. J. (1985) Extramammary Paget's disease: prognosis and relationship to internal malignancy. Journal of the American Academy of Dermatology, 13, 1009–1014.
  • Crawford D., Nimmo M., Clement P. B., Thomson T., Benedet J. L., Miller D. and Gilks C. B. (1999) Prognostic factors in Paget's disease of the vulva: a study of 21 cases. International Journal of Gynecological Pathology, 18, 351–359.
  • Del Castillo L. F., Garcia C., Schoendorff C., Garcia J. F., Torres L. M. and Garcia Almagro D. (2000) Spontaneous apparent clinical resolution with histologic persistence of a case of extramammary Paget's disease: response to topical 5-fluorouracil. Cutts, 65, 331–333.
  • Diaz de Leon E., Carcangiu M. L., Prieto V. G., McCue P. A., Burchette J. L., To G., Norris B. A., Kovatich A. J., Sanchez R. L., Krigman H. R. and Gatalica Z. (2000) Extramammary Paget disease is characterised by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor. American Journal of Clinical Pathology, 113, 572 — 575.
  • Ellis P. E., Wong Te Fong L. F., Rolfe K. J., Crow J. C., Reid W. M. N., Davidson T., MacLean A. B. and Perrett C. W. (2002) The role of p53 and Ki 67 in Paget's disease of the vulva and the breast. Gynacologic Oncology, 86, 150–156.
  • Ellis P. E., Wong Te Fong L. F., Rolfe K. J., Crow J. C., Reid W. M. N., Davidson T., MacLean A. B. and Perrett C. W. (2002) The role of vascular endothelial growth factor-A (VEGF-A) and platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) in Paget's disease of the vulva and breast. Anticancer Research, 22, 857— 862.
  • Fanning J., Lambert H. C., Hale T. M., Morris P. C. and Schuerch C. (1999) Paget's disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision. American Journal of Obstetrics and Gynecology, 180, 24–27.
  • Farrell A. M., Charnock F. M., Millard P. R. and Wojnar-owska F. (1999) Paget's disease of the vulva associated with local adenocarcinoma and previous breast adenocarcinoma: report of two cases. British Journal of Dermatology, 14, 146–149.
  • Fishman D. A., Chambers S. K., Schwartz P. E., Kohorn E. I. and Chambers J. T. (1995) Extramammary Paget's disease of the vulva. Gynecologic Oncology, 56, 266–270.
  • Fujimoto A., Takata M., Hatta N. and Takehara K. (2000) Expression of structurally unaltered androgen receptor in extramammary Paget's disease. Laboratory Investigation, 80, 1465 — 1471.
  • Goldblum J. R. and Hart W. R. (1997) Vulvar Paget's disease: a clinicopathologic and immunohistochemical study of 19 cases. American Journal of Surgical Pathology, 21, 1178–1187.
  • Goldblum J. R. and Hart W. R. (1998) Perianal Paget's disease: a histologic and immunohistochemical study of 11 cases with and without associated rectal adencarcinoma. American Journal of Surgical Pathology, 22, 170— 179.
  • Henta T., Itoh Y., Kobayashi M., Ninomiya Y. and Ishibashi A. (1999) Photodynamic therapy for inoperable vulval Paget's disease using delta-aminolaevulinic acid: successful management of a large skin lesion. British Journal of Dermatology, 141, 347–349.
  • Kodama S., Kaneko T., Saito M., Yoshiya N., Honma S. and Tanaka K. (1995) A clinicopathologic study of 30 patients with Paget's disease of the vulva. Gynaecologic Oncology, 56, 63–70.
  • Kohler S. and Smoller B. R. (1996) Gross cystic disease fluid protein-15 reactivity in extramammary Paget's disease with and without associated internal malignancy. American Journal of Dermatopathology, 18, 118–123.
  • Lam D. T., Batista O., Weiss E. G., Nogueras J. J. and Wexner S. D. (2001) Staged excision and split-thickness skin graft for circumferential perianal Paget's disease. Diseases of the Colon and Rectum, 44, 868–870.
  • MacLean A. B., Roberts D. T. and Reid W. M. N. (1998) Review of 1000 women seen at two specially designated vulval clinics. Current Obstetrics and Gynaecology, 8, 159 — 162.
  • MacLean A. B. (2000) Paget's disease of the vulva. Journal of Obstetrics and Gynaecology, 20, 7–9.
  • Marchesa P., Fazio V. W., Oliart S., Goldblum J. R., Lavery I. C. and Milsom J. W. (1997) Long-term outcome of patients with perianal Paget's disease. Annals of Surgical Oncology, 4, 475–480.
  • Nowak M. A., Guerriere-Kovach P., Pathan A., Campbell T. E. and Deppisch L. M. (1998) Perianal Paget's disease: distinguishing primary and secondary lesions using immunohistochemical studies including gross cystic disease fluid protein-15 and cytokeratin 20 expression. Archives of Pathology and Laboratory Medicine, 122, 1077 — 1081.
  • Oguchi S., Kaneko M., Uhara H. and Saidi T. (2002) Docetaxel induced durable response in advanced extramammary Paget's disease: a case report. Journal of Dermatology, 29, 33–37.
  • Ohnishi T. and Watanabe S. (2000) The use of cytokeratins 7 and 20 in the diagnosis of primary and secondary extra-mammmary Paget's disease. British Journal of Dermatology, 142, 243–247.
  • Paget J. (1874) On disease of the mammary areola preceding cancer of the mammary gland. St Bartholomew's Hospital Reports, 10, 87.
  • Parker L. P., Parker J. R., Bodurka-Bevers D., Deavers M., Bevers M. W., Shen-Gunther J. and Gershenson D. M. (2000) Paget's disease of the vulva: pathology, pattern of involvement and prognosis. Gynecologic Oncology, 77, 183 — 189.
  • Preti M., Micheletti L., Ghiringhello B., Privitera S., Condollo V., Chieppa P. and Massobrio M. (2000) La malattia di Paget vulvare. Revisione clinico-patologica della letteratura. Miner-va Ginecologica, 52, 203–211.
  • Ricchi E., Fundaro S., Spallanzani A., Carriero A., Farinetti A., Ferrara F. and Pezcoller C. (1996) Vertical subcutaneous pedicle flaps for posterior perineal reconstruction. Report of three cases. Diseases of the Colon and Rectum, 39, 353–357.
  • Runfola M. A., Weber T. K., Rodriguez-Bigas M. A., Dougherty T. J. and Petrelli N. J. (2000) Photodynamic therapy for residual neoplasms of the perianal skin. Diseases of the Colon and Rectum, 43, 499–502.
  • Sarmiento J. M., Wolff B. G., Burgart L. J., Frizelle F. A. and Ilstrup D. M. (1997) Paget's disease of the perianal region: an aggressive disease? Diseases of the Colon and Rectum, 40, 1187— 1194.
  • Sasaki K., Nozaki M., Kikutchi Y., Yamaki T. and Soejima K. (1999) Reconstruction of the perianal skin defect using a V — Y advancement of bilateral gluteus maximus musculocuta-neous flaps: reconstruction considering anal cleft and anal function. British Journal of Plastic Surgery, 52, 471 — 475.
  • Smith K. J., Tuur S., Corvette D., Lupton G. P. and Skelton H. G. (1997) Cytokeratin 7 staining in mammary and extra-mammmary Paget's disease. Modern Pathology, 10, 1069 — 1074.
  • Stacy D., Burrell M. O. and Franklin E. W. (1986) Extra-mammary Paget's disease of the vulva and anus: use of intraoperative frozen-section margins. American Journal of Obstetrics and Gynecology, 155, 519— 523.
  • Tidy J. A., Soutter W. P., Luesley D. M., MacLean A. B., Buckley C. H. and Ridley C. M. (1996) Management of lichen sclerosus and intraepithelial neoplasia of the vulva in the UK. Journal of the Royal Society of Medicine, 89, 699 — 701.
  • Watanabe Y., Hoshiai A., Ueda H., Nakai H., Obata K. and Noda K. (2002) Low-dose mitomycin C, etoposide and cisplatin for invasive vulvar Paget's diseae. International Journal of Gynecological Cancer, 12, 304 —307.
  • Wilkinson R. J. and Brown H. (2002) Vulvar Paget disease of urothelial origin: a report of three cases and a proposed classification of vulvar Paget disease. Human Pathology, 33, 549— 554.
  • Yamazaki N., Yamamoto A., Wada T., Ishikawa M., Moriya Y. and Nakanishi Y. (1999) A case of metastatic extra-mammary Paget's disease that responded to combination chemotherapy. Journal of Dermatology, 26, 311 —316.
  • Yugueros P., Keeney G. K. and Bite U. (1997) Paget's disease of the groin: report of seven cases. Plastic and Reconstructive Surgery, 100, 336–339.
  • Zollo J. D. & Zeitouni N. C. (2000) The Roswell Park Cancer Institute experience with extramammary Paget's disease. British Journal of Dermatology, 142, 59–65.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.